Julien Vergniol
Overview
Explore the profile of Julien Vergniol including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
53
Citations
3256
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Brayette A, Essig M, Carrier P, Debette-Gratien M, Labrunie A, Alain S, et al.
World J Hepatol
. 2021 Jan;
12(12):1326-1340.
PMID: 33442458
Background: The recommended monitoring tools for evaluating nucleot(s)ide analogue renal toxicity, such as estimated glomerular filtration rate (eGFR) and phosphatemia, are late markers of proximal tubulopathy. Multiple early markers are...
2.
Turpin A, De Baere T, Heurgue A, Le Malicot K, Ollivier-Hourmand I, Lecomte T, et al.
Clin Res Hepatol Gastroenterol
. 2020 Jun;
45(2):101464.
PMID: 32576496
Background: Trans-arterial chemoembolization (TACE) is one first-line option therapy for patients with hepatocellular carcinoma (HCC) not suitable for surgical resection. Aims: We evaluated the effects of sunitinib plus doxorubicin-TACE on...
3.
Bernardot L, Roman S, Barret M, Vitton V, Wallenhorst T, Pioche M, et al.
Surg Endosc
. 2020 Jan;
34(12):5508-5515.
PMID: 31932930
Introduction: Per-oral endoscopic myotomy (POEM) is effective in achalasia. The objective of this study was to evaluate the short-term clinical efficacy of POEM in non-achalasia esophageal motility disorders (NAEMD). Patients...
4.
Petta S, Wong V, Bugianesi E, Fracanzani A, Camma C, Hiriart J, et al.
Am J Gastroenterol
. 2019 Jun;
114(6):916-928.
PMID: 31169533
Introduction: Some evidence suggests an interference of obesity and alanine aminotransferase (ALT) levels on the diagnostic accuracy for advanced fibrosis of noninvasive tools such as liver stiffness measurement (LSM) by...
5.
Jouve J, Lecomte T, Bouche O, Barbier E, Akouz F, Riachi G, et al.
J Hepatol
. 2019 May;
71(3):516-522.
PMID: 31125576
Background & Aims: Sorafenib is the standard of care for advanced hepatocellular carcinoma (HCC). Combining sorafenib with another treatment, to improve overall survival (OS) within an acceptable safety profile, might...
6.
Gominon A, Frison E, Hiriart J, Vergniol J, Clouzeau H, Enaud R, et al.
J Pediatr Gastroenterol Nutr
. 2017 Nov;
66(3):455-460.
PMID: 29112089
Objectives: Cystic fibrosis-related liver disease (CFLD) can develop silently in early life and approximately 10% of children with cystic fibrosis (CF) become cirrhotic before adulthood. Clinical, biological, and ultrasound criteria...
7.
Thabut D, Pauwels A, Carbonell N, Remy A, Nahon P, Causse X, et al.
J Hepatol
. 2017 Sep;
68(1):73-81.
PMID: 28918131
Background: The Baveno VI consensus meeting concluded that an early TIPS must be considered in high-risk cirrhotic patients presenting with variceal bleeding (VB) (Child B + active bleeding at endoscopy...
8.
Ducancelle A, Leroy V, Vergniol J, Sturm N, Le Bail B, Zarski J, et al.
J Clin Gastroenterol
. 2017 Jul;
51(7):639-649.
PMID: 28692443
Background And Goal: International guidelines suggest combining a blood test and liver stiffness measurement (LSM) to stage liver fibrosis in chronic hepatitis C (CHC) and non-alcoholic fatty liver disease (NAFLD)....
9.
de Ledinghen V, Hiriart J, Vergniol J, Merrouche W, Bedossa P, Paradis V
Dig Dis Sci
. 2017 Jun;
62(9):2569-2577.
PMID: 28577247
Introduction: Controlled attenuation parameter (CAP) is a new method for the diagnosis of steatosis. Until now, CAP was available only with the M probe of the Fibroscan. The aim of...
10.
Validity criteria for the diagnosis of fatty liver by M probe-based controlled attenuation parameter
Wong V, Petta S, Hiriart J, Camma C, Wong G, Marra F, et al.
J Hepatol
. 2017 May;
67(3):577-584.
PMID: 28506907
Background & Aims: Controlled attenuation parameter (CAP) can be performed together with liver stiffness measurement (LSM) by transient elastography (TE) and is often used to diagnose fatty liver. We aimed...